PROQR THERAPEUTICS EO-04 (0PQ) — Free Cash Flow Generation Index

Latest as of December 2023: 0.94x

PROQR THERAPEUTICS EO-04 (0PQ) has a Free Cash Flow Generation Index of 0.94x as of December 2023. Free cash flow of €20.18 Million represents 1% of operating cash flow (€21.55 Million). See PROQR THERAPEUTICS EO-04 short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.94x

Free Cash Flow / Operating CF

Free Cash Flow

€20.18 Million

EUR

Operating Cash Flow

€21.55 Million

EUR

Capital Expenditures

€1.37 Million

EUR

PROQR THERAPEUTICS EO-04 Free Cash Flow Generation Index (2023–2023)

Historical FCF Generation Index trend for PROQR THERAPEUTICS EO-04 across 1 annual periods. Explore 0PQ debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for PROQR THERAPEUTICS EO-04 (2023–2023)

Year-by-year Free Cash Flow Generation Index for PROQR THERAPEUTICS EO-04. For the full company profile including market capitalisation, see market value of PROQR THERAPEUTICS EO-04.

Year	FCG Index	Free Cash Flow (EUR)	Operating CF	Capital Expenditures	YoY Change
2023	0.94x	€20.18 Million	€21.55 Million	€1.37 Million	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).